The pathogenesis of systemic lupus erythematosus - From the viewpoint of oxidative stress and mitochondrial dysfunction

Mitochondrion

Volumn 30, Issue , 2016, Pages 1-7

  Lee, Hui Ting ^a,b   Wu, Tsai Hung ^c,d   Lin, Chen Sung ^d,e   Lee, Chyou Shen ^a,b,f   Wei, Yau Huei ^b,d   Tsai, Chang Youh ^c,d   Chang, Deh Ming ^c,d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b MACKAY MEDICAL COLLEGE   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e FENG YUAN HOSPITAL   (Taiwan)

^f NURSING AND MANAGEMENT COLLEGE   (Taiwan)

Author keywords

NETosis; Pentose phosphate pathway; Reactive oxygen species; Redox reaction; Systemic lupus erythematosus

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

APOPTOSIS; CYTOKINE PRODUCTION; DETOXIFICATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GLUCOSE METABOLISM; HETEROPLASMY; HUMAN; HUMAN CELL CULTURE; LYMPHOCYTE; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ENERGY METABOLISM; METABOLISM; MITOCHONDRION; PATHOLOGY; PATHOPHYSIOLOGY;

ENERGY METABOLISM; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84973380270     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2016.05.007     Document Type: Review

References (84)

1. Abraham E. Nuclear factor-kappa B and its role in sepsis-associated organ failure. J. Infect. Dis. 2003, 187(Suppl. 2):S364-S369.
2. Alfadda A.A., Sallam R.M. Reactive oxygen species in health and disease. J. Bioenerg. Biomembr. 2012, 2012:936486.
3. Almyroudis N.G., Grimm M.J., Davidson B.A., Rohm M., Urban C.F., Segal B.H. NETosis and NADPH oxidase: at the intersection of host defense, inflammation, and injury. Front. Immunol. 2013, 4:45.
4. Badr G., Borhis G., Lefevre E.A., Chaoul N., Deshayes F., Dessirier V., Lapree G., Tsapis A., Richard Y. BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood 2008, 111:2744-2754.
5. Banki K., Hutter E., Gonchoroff N.J., Perl A. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J. Immunol. 1999, 162:1466-1479.
6. Barrajon-Catalan E., Herranz-Lopez M., Joven J., Segura-Carretero A., Alonso-Villaverde C., Menendez J.A., Micol V. Molecular promiscuity of plant polyphenols in the management of age-related diseases: far beyond their antioxidant properties. Adv. Exp. Med. Biol. 2014, 824:141-159.
7. Bengtsson A.A., Gullstrand B., Truedsson L., Sturfelt G. SLE serum induces classical caspase-dependent apoptosis independent of death receptors. Clin. Immunol. 2008, 126:57-66.
8. Blank M., Shoenfeld Y., Perl A. Cross-talk of the environment with the host genome and the immune system through endogenous retroviruses in systemic lupus erythematosus. Lupus 2009, 18:1136-1143.
9. Campbell A.M., Kashgarian M., Shlomchik M.J. NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci. Transl. Med. 2012, 4.
10. Casciola-Rosen L.A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 1994, 179:1317-1330.
11. Chung H.Y., Kim H.J., Kim K.W., Choi J.S., Yu B.P. Molecular inflammation hypothesis of aging based on the anti-aging mechanism of calorie restriction. Microsc. Res. Tech. 2002, 59:264-272.
12. Cordova E.J., Velazquez-Cruz R., Centeno F., Baca V., Orozco L. The NRF2 gene variant, -653G/a, is associated with nephritis in childhood-onset systemic lupus erythematosus. Lupus 2010, 19:1237-1242.
13. de Boer V.C., Houten S.M. A mitochondrial expatriate: nuclear pyruvate dehydrogenase. Cell 2014, 158:9-10.
14. Domann F.E. Aberrant free radical biology is a unifying theme in the etiology and pathogenesis of major human diseases. Int. J. Mol. Sci. 2013, 14:8491-8495.
15. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82:47-95.
16. Dwivedi N., Radic M. Citrullination of autoantigens implicates NETosis in the induction of autoimmunity. Ann. Rheum. Dis. 2014, 73:483-491.
17. Eisele H.J., Markart P., Schulz R. Obstructive sleep apnea, oxidative stress, and cardiovascular disease: evidence from human studies. Oxidative Med. Cell. Longev. 2015, 2015:608438.
18. El-Benna J., Dang P.M., Gougerot-Pocidalo M.A. Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane. Semin. Immunopathol. 2008, 30:279-289.
19. Gergely P., Grossman C., Niland B., Puskas F., Neupane H., Allam F., Banki K., Phillips P.E., Perl A. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 2002, 46:175-190.
20. Guo G., Meng Y., Tan W., Xia Y., Cheng C., Chen X., Gu Z. Induction of apoptosis coupled to endoplasmic reticulum stress through regulation of CHOP and JNK in bone marrow Mesenchymal stem cells from patients with systemic lupus erythematosus. J. Immunol. Res. 2015, 2015:183738.
21. Guo Y., Yu S., Zhang C., Tony Kong A.N. Epigenetic regulation of Keap1-Nrf2 signaling. Free Radic. Biol. Med. 2015.
22. Hahn S., Giaglis S., Chowdhury C.S., Hosli I., Hasler P. Modulation of neutrophil NETosis: interplay between infectious agents and underlying host physiology. Semin. Immunopathol. 2013, 35:439-453.
23. Hassan S.Z., Gheita T.A., Kenawy S.A., Fahim A.T., El-Sorougy I.M., Abdou M.S. Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int. J. Rheum. Dis. 2011, 14:325-331.
24. Hirabayashi Y., Oka Y., Ikeda T., Fujii H., Ishii T., Sasaki T., Harigae H. The endoplasmic reticulum stress-inducible protein, Herp, is a potential triggering antigen for anti-DNA response. J. Immunol. 2010, 184:3276-3283.
25. Hurtado-Nedelec M., Makni-Maalej K., Gougerot-Pocidalo M.A., Dang P.M., El-Benna J. Assessment of priming of the human neutrophil respiratory burst. Methods Mol. Biol. 2014, 1124:405-412.
26. Jeon S.M., Chandel N.S., Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 2012, 485:661-665.
27. Kansanen E., Kuosmanen S.M., Leinonen H., Levonen A.L. The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol. 2013, 1:45-49.
28. Knight J.S., Carmona-Rivera C., Kaplan M.J. Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases. Front. Immunol. 2012, 3:380.
29. Kondoh H., Lleonart M.E., Gil J., Wang J., Degan P., Peters G., Martinez D., Carnero A., Beach D. Glycolytic enzymes can modulate cellular life span. Cancer Res. 2005, 65:177-185.
30. Kowaltowski A.J., Vercesi A.E. Mitochondrial damage induced by conditions of oxidative stress. Free Radic. Biol. Med. 1999, 26:463-471.
31. Lai Z.W., Hanczko R., Bonilla E., Caza T.N., Clair B., Bartos A., Miklossy G., Jimah J., Doherty E., Tily H., Francis L., Garcia R., Dawood M., Yu J., Ramos I., Coman I., Faraone S.V., Phillips P.E., Perl A. N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2012, 64:2937-2946.
32. Lee H.C., Wei Y.H. Mitochondrial role in life and death of the cell. J. Biomed. Sci. 2000, 7:2-15.
33. Lee H.C., Wei Y.H. Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int. J. Biochem. Cell Biol. 2005, 37:822-834.
34. Lee H.C., Wei Y.H. Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp. Biol. Med. 2007, (Maywood, N.J 232, 592-606).
35. Lee H.T., Shiao Y.M., Wu T.H., Chen W.S., Hsu Y.H., Tsai S.F., Tsai C.Y. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. J. Rheumatol. 2010, 37:45-52.
36. Lee H.T., Lin C.S., Chen W.S., Liao H.T., Tsai C.Y., Wei Y.H. Leukocyte mitochondrial DNA alteration in systemic lupus erythematosus and its relevance to the susceptibility to lupus nephritis. Int. J. Mol. Sci. 2012, 13:8853-8868.
37. Lee H.T., Lin C.S., Lee C.S., Tsai C.Y., Wei Y.H. Increased 8-hydroxy-2'-deoxyguanosine in plasma and decreased mRNA expression of human 8-oxoguanine DNA glycosylase 1, anti-oxidant enzymes, mitochondrial biogenesis-related proteins and glycolytic enzymes in leucocytes in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 2014, 176:66-77.
38. Lee H.T., Wu T.H., Lin C.S., Lee C.S., Pan S.C., Chang D.H., Wei Y.H., Tsai C.Y. DNA damage and mitochondrial DNA alteration in patients with systemic lupus erythematosus. Front. Biosci. 2016, (in press).
39. Lei Y., Wang K., Deng L., Chen Y., Nice E.C., Huang C. Redox regulation of inflammation: old elements, a new story. Med. Res. Rev. 2015, 35:306-340.
40. Li K.J., Wu C.H., Hsieh S.C., Lu M.C., Tsai C.Y., Yu C.L. Deranged bioenergetics and defective redox capacity in T lymphocytes and neutrophils are related to cellular dysfunction and increased oxidative stress in patients with active systemic lupus erythematosus. Clin. Dev. Immunol. 2012, 2012:548516.
41. Lightowlers R.N., Chinnery P.F., Turnbull D.M., Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet. 1997, 13:450-455.
42. Lood C., Blanco L.P., Purmalek M.M., Carmona-Rivera C., De Ravin S.S., Smith C.K., Malech H.L., Ledbetter J.A., Elkon K.B., Kaplan M.J. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med. 2016, 22:146-153.
43. Lu F. Reactive oxygen species in cancer, too much or too little?. Med. Hypotheses 2007, 69:1293-1298.
44. Lunec J., Herbert K., Blount S., Griffiths H.R., Emery P. 8-Hydroxydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett. 1994, 348:131-138.
45. Macdonald P., Palmer J., Kirby J.A., Jones D.E. Apoptosis as a mechanism for cell surface expression of the autoantigen pyruvate dehydrogenase complex. Clin. Exp. Immunol. 2004, 136:559-567.
46. Manganelli G., Masullo U., Passarelli S., Filosa S. Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits. Cardiovasc. Hematol. Dis. Drug Targets 2013, 13:73-82.
47. Mansour R.B., Lassoued S., Gargouri B., El Gaid A., Attia H., Fakhfakh F. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand. J. Rheumatol. 2008, 37:103-108.
48. Mohammed B.M., Fisher B.J., Kraskauskas D., Farkas D., Brophy D.F., Fowler A.A., Natarajan R. Vitamin C: a novel regulator of neutrophil extracellular trap formation. Nutrition 2013, 5:3131-3151.
49. Moore C.B., Bergstralh D.T., Duncan J.A., Lei Y., Morrison T.E., Zimmermann A.G., Accavitti-Loper M.A., Madden V.J., Sun L., Ye Z., Lich J.D., Heise M.T., Chen Z., Ting J.P. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008, 451:573-577.
50. Morgan P.E., Sturgess A.D., Davies M.J. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum. 2005, 52:2069-2079.
51. Morgan P.E., Sturgess A.D., Hennessy A., Davies M.J. Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis. Free Radic. Res. 2007, 41:1301-1312.
52. Morgan P.E., Sturgess A.D., Davies M.J. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic. Res. 2009, 43:117-127.
53. Muller S., Radic M. Oxidation and mitochondrial origin of NET DNA in the pathogenesis of lupus. Nat. Med. 2016, 22:126-127.
54. Obermoser G., Pascual V. The interferon-alpha signature of systemic lupus erythematosus. Lupus 2010, 19:1012-1019.
55. Pedersen P.L. Warburg, me and hexokinase 2: multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg effect", i.e., elevated glycolysis in the presence of oxygen. J. Bioenerg. Biomembr. 2007, 39:211-222.
56. Perl A. Pathogenic mechanisms in systemic lupus erythematosus. Autoimmunity 2010, 43:1-6.
57. Perl A., Gergely P., Banki K. Mitochondrial dysfunction in T cells of patients with systemic lupus erythematosus. Int. Rev. Immunol. 2004, 23:293-313.
58. Perl A., Gergely P., Nagy G., Koncz A., Banki K. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol. 2004, 25:360-367.
59. Perl A., Nagy G., Gergely P., Puskas F., Qian Y., Banki K. Apoptosis and mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods Mol. Med. 2004, 102:87-114.
60. Perl A., Hanczko R., Doherty E. Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods Mol. Biol. 2012, 900:61-89.
61. Picceli V.F., Skare T.L., Nisihara R., Kotze L., Messias-Reason I., Utiyama S.R. Spectrum of autoantibodies for gastrointestinal autoimmune diseases in systemic lupus erythematosus patients. Lupus 2013, 22:1150-1155.
62. Pieterse E., van der Vlag J. Breaking immunological tolerance in systemic lupus erythematosus. Front. Immunol. 2014, 5:164.
63. Pothlichet J., Niewold T.B., Vitour D., Solhonne B., Crow M.K., Si-Tahar M. A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients. EMBO Mol. Med. 2011, 3:142-152.
64. Robbesyn F., Salvayre R., Negre-Salvayre A. Dual role of oxidized LDL on the NF-kappa B signaling pathway. Free Radic. Res. 2004, 38:541-551.
65. Salvioli S., Capri M., Valensin S., Tieri P., Monti D., Ottaviani E., Franceschi C. Inflamm-aging, cytokines and aging: state of the art, new hypotheses on the role of mitochondria and new perspectives from systems biology. Curr. Pharm. Des. 2006, 12:3161-3171.
66. Shah D., Kiran R., Wanchu A., Bhatnagar A. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity. Immunol. Lett. 2010, 129:7-12.
67. Shah D., Aggarwal A., Bhatnagar A., Kiran R., Wanchu A. Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus. Free Radic. Res. 2011, 45:559-567.
68. Shah D., Sah S., Nath S.K. Interaction between glutathione and apoptosis in systemic lupus erythematosus. Autoimmun. Rev. 2013, 12:741-751.
69. Shah D., Sah S., Wanchu A., Wu M.X., Bhatnagar A. Altered redox state and apoptosis in the pathogenesis of systemic lupus erythematosus. Immunobiology 2013, 218:620-627.
70. Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015, 4:180-183.
71. +-potential as a convertible energy source for the living cell. FEBS Lett. 1977, 74:1-9.
72. Sun C., Liu X., Zhang H., Guo W., Cai Z., Chen H., Zhang K., Zhu D., Wang Y. Functional polymorphism of hOGG1 gene is associated with type 2 diabetes mellitus in Chinese population. Mol. Cell. Endocrinol. 2010, 325:128-134.
73. Sutendra G., Kinnaird A., Dromparis P., Paulin R., Stenson T.H., Haromy A., Hashimoto K., Zhang N., Flaim E., Michelakis E.D. A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation. Cell 2014, 158:84-97.
74. Taysi S., Gul M., Sari R.A., Akcay F., Bakan N. Serum oxidant/antioxidant status of patients with systemic lupus erythematosus. Clin. Chem. Lab. Med. 2002, 40:684-688.
75. Ting J.P., Duncan J.A., Lei Y. How the noninflammasome NLRs function in the innate immune system. Science 2010, 327:286-290.
76. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
77. Wahl D.R., Petersen B., Warner R., Richardson B.C., Glick G.D., Opipari A.W. Characterization of the metabolic phenotype of chronically activated lymphocytes. Lupus 2010, 19:1492-1501.
78. Wallace D.C., Chalkia D. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb. Perspect. Biol. 2013, 5.
79. West A.P., Shadel G.S., Ghosh S. Mitochondria in innate immune responses. Nat. Rev. Immunol. 2011, 11:389-402.
80. West A.P., Khoury-Hanold W., Staron M., Tal M.C., Pineda C.M., Lang S.M., Bestwick M., Duguay B.A., Raimundo N., MacDuff D.A., Kaech S.M., Smiley J.R., Means R.E., Iwasaki A., Shadel G.S. Mitochondrial DNA Stress Primes the Antiviral Innate Immune Response 2015, (Nature advance online publication).
81. Willems P.H., Rossignol R., Dieteren C.E., Murphy M.P., Koopman W.J. Redox homeostasis and mitochondrial dynamics. Cell Metab. 2015, 22:207-218.
82. Wright H.L., Moots R.J., Edwards S.W. The multifactorial role of neutrophils in rheumatoid arthritis. Nat. Rev. Rheumatol. 2014, 10:593-601.
83. Wu T., Xie C., Han J., Ye Y., Weiel J., Li Q., Blanco I., Ahn C., Olsen N., Putterman C., Saxena R., Mohan C. Metabolic disturbances associated with systemic lupus erythematosus. PLoS One 2012, 7.
84. Yoh K., Itoh K., Enomoto A., Hirayama A., Yamaguchi N., Kobayashi M., Morito N., Koyama A., Yamamoto M., Takahashi S. Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int. 2001, 60:1343-1353.